Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
Inpatient Glucose Management: Part 2
ADA and Joint Commission Guidelines for Best Practices
In part 1 of this series, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and hospital-acquired conditions.
The American Diabetes Association (ADA) and The Joint Commission have created recommendations for diabetes care in the hospital. Some of the best practices include:
- Insulin – The preferred method of glycemic control in the hospital setting.
- Sliding scale – This retrospective method of insulin dosing is strongly discouraged in the hospital setting as the sole method of treatment.
- Glucose range – Once insulin therapy begins, a target glucose range of 140-180 mg/dL (7.8-10.0 mmol/L) is recommended for most critically ill and non-critically ill patients.
- Stringent targets – The target range of 110-140 mg/dL is appropriate for select critically ill patients without increasing the risk of hypoglycemia.
In part 3 of this series, we will uncover the facts behind the positive outcomes of inpatient glucose control.
Related posts

Blog
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
As a former Director of Nursing and now the leader of a national team focused on implementing a clinical decision support tool for glycemic management, I have had the unique opportunity to guide health systems through the operational and clinical ...

Blog
Lessons from the Frontline: How EndoTool Helps Nurse Leaders Scale Best Practices
Lessons from the Frontline: How EndoTool Helps Nurse Leaders Scale Best Practices
Before joining Monarch, glycemic management was a regular part of my nursing life. Whether I was a new grad in the pediatric emergency and trauma department, starting insulin drips during pediatric critical care transport, or managing adult patients in a ...

Blog
Clinical Impact, Regulatory Wins, and Trusted Innovation
Clinical Impact, Regulatory Wins, and Trusted Innovation
CEO Update Q2 2025 This quarter, the impact of EndoTool came into even sharper focus - not just through what we say, but through what our customers are proving in practice. At this year's AACE Annual Meeting, new research from ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields